Avinger announces filing of 510(k) submission for tigereye st image-guided cto crossing system

Redwood city, ca / accesswire / july 6, 2022 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of peripheral artery disease (pad), today announced the company has submitted a 510(k) application to the u.s. food & drug administration (fda) for the tigereye st catheter, a next generation chronic total occlusion (cto) crossing system utilizing avinger's proprietary image-guided technology platform. tigereye st is a next generation line extension of avinger's ocelot and tigereye™ family of cto crossing catheters.
AVGR Ratings Summary
AVGR Quant Ranking